Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab

NCT02330562 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Glioma
Glioblastoma

Interventions

DRUG: MRZ
DRUG: BEV

Sponsor

Celgene

Collaborators

[object Object]